Stanford Biotechnology Group

Stanford Biotech Group Podcast

Science EN ↓ 4 episodes

The Stanford Biotech Group Podcast is your front-row seat to the people shaping the future of the life sciences. Run by Stanford graduate and professional students across PhD, MD, MBA, and MS programs, we sit down with the scientists, founders, and investors driving biotech forward. Let's pulling back the curtain on the breakthroughs, bets, and big ideas redefining medicine!

Author

Stanford Biotechnology Group

Category

Science

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Who Owns the Discovery? Biotech Patents and AI with Julia Minitti 17.11.2026

What should you think about before sharing a discovery in a preprint, on a conference poster, or with a chatbot? Host Afi Tagnedji sits down with Julia Minitti, a Wilson Sonsini patent partner and former medicinal chemist, to talk about when to file a patent, what investors look for in a biotech startup’s intellectual property, and who gets credit when AI helps design a drug. Julia also shares wha...

The Future of Farming Is Biotech 02.11.2026

In this episode of the Stanford Biotech Group Podcast, our Co-VP of Communications, Mikaela Ribi, sits down with Tim Schnabel, founder and CEO of Switch Bioworks, a Stanford spinout engineering microbes to produce sustainable nitrogen fertilizer. Together, we explore his journey from PhD research to entrepreneurship, the challenges of translating scientific discoveries into practical solutions, an...

World-Class Science. But Where Are Australia’s Biotechs? 21.10.2026

Our guest is Dr. Bob Soh, a partner at Brandon Capital, Australia’s biggest life sciences venture capital firm. Bob talks with Rui Yip about why Australia’s strong research base hasn’t produced a bigger biotech industry, and why overseas biotechs often run their Phase 1 trials here. They also cover how veterans of big pharma are helping launch new companies, how the local pool of biotech venture c...

Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic 13.05.2026

Caitlyn Miller, CEO and co-founder of TwoStep Therapeutics, joins the SBG podcast to discuss her Series A biotech's five-target peptide platform for solid tumors, the path from Stanford PhD to funded company, and what no one tells you about founding.

Listen to the Stanford Biotech Group Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.